Call our 24 hours, seven days a week helpline at 800.272.3900

24/7 Helpline 800.272.3900
Donate

Alzheimer's Association Statement Regarding Washington Post Article on Pfizer/Amgen Enbrel Decision in Alzheimer’s

Alzheimer's Association Statement Regarding Washington Post Article on Pfizer/Amgen Enbrel Decision in Alzheimer’s
Share or Print this page
Share or Print this page
June 5, 2019
Email: media@alz.org
Share or Print this page
CHICAGO, June 5, 2019 — “Any science that has promise for Alzheimer’s disease and other dementias and is not genuinely pursued, or shared with the research community, does a disservice to the millions of individuals facing the disease today and in the future. Alzheimer's is a personally devastating and fatal disease, the sixth leading cause of death in the United States, with the number of people impacted by the disease increasing daily. No stone should be left unturned. The expectation of the Alzheimer’s Association and our millions of constituents is that every possible path is pursued thoroughly and aggressively with people living with the disease as a priority.”

— Maria C. Carrillo, Ph.D., chief science officer, Alzheimer’s Association
 

Alzheimer's Association

The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia.™ For more information, visit www.alz.org or call the 24/7 Helpline at 800.272.3900.

Keep Up With Alzheimer’s News and Events